Barriers and Facilitators to Oral PrEP Use Among Transgender Women in New York City |
| |
| Authors: | Christine Tagliaferri Rael Michelle Martinez Rebecca Giguere Walter Bockting Caitlin MacCrate Will Mellman Pablo Valente George J. Greene Susan Sherman Katherine H. A. Footer Richard T. D’Aquila Alex Carballo-Diéguez |
| |
| Affiliation: | 1.HIV Center for Clinical and Behavioral Studies at the New York State Psychiatric Institute and Columbia University,New York,USA;2.Program for the Study of LGBT Health at the New York State Psychiatric Institute/Columbia Psychiatry and the Columbia University School of Nursing,New York,USA;3.CUNY School of Public Health,New York,USA;4.Columbia University Mailman School of Public Health,New York,USA;5.Department of Medical Social Sciences,Northwestern University Feinberg School of Medicine,Chicago,USA;6.Department of Behavior and Society,Johns Hopkins Bloomberg School of Public Health,Baltimore,USA;7.Division of Infectious Diseases, Department of Medicine,Northwestern University Feinberg School of Medicine,Chicago,USA |
| |
| Abstract: | Transgender women may face a disparate risk for HIV/AIDS compared to other groups. In 2012, Truvada was approved for daily use as HIV pre-exposure prophylaxis (PrEP). However, there is a dearth of research about barriers and facilitators to PrEP in transgender women. This paper will shed light on transgender women living in New York City’s perceived and actual challenges to using PrEP and potential strategies to overcome them. After completing an initial screening process, four 90-min focus groups were completed with n?=?18 transgender women. Participants were asked what they like and dislike about PrEP. Participants identified the following barriers: uncomfortable side effects, difficulty taking pills, stigma, exclusion of transgender women in advertising, and lack of research on transgender women and PrEP. Facilitators included: reducing pill size, increasing the types of available HIV prevention products, and conducting scientific studies to evaluate PrEP in transgender women. |
| |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ |
|
